Atlas FDA

AIM-V (R) MEDIUM, MODEL 087-0112

FDA 510(k) clearance K022086 · decided 2002-12-23

Clearance details

K-number
K022086
Device name
AIM-V (R) MEDIUM, MODEL 087-0112
Applicant
Invitrogen Corporation
Decision
Substantially Equivalent
Date received
2002-06-27
Decision date
2002-12-23
Days to decision
179 days
Clearance type
Traditional
Product code
NDS
Device class
2
Regulation number
876.5885
Medical specialty
Gastroenterology, Urology
Advisory committee
Gastroenterology, Urology
Location
Grand Island, NY, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Invitrogen Corporation

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
MSC SFM (K232543)Yocon Biology Technology Company2024-09-06
“MoFi” Cell Culture Basal Medium (K240247)Duogenic Stemcells Corporation2024-07-12
PRIME-XV FreezIS DMSO-Free MD (K231804)Fujifilm Irvine Scientific2023-11-09
CT-STOR (K201789)Energy Delivery Solutions2021-09-20
OPTMIZER CTS T-CELL EXPANSION SERUM FREE MEDIUM (K113566)Life Technologies, Inc.2012-06-21
STEMPRO MSC SFM (K103302)Life Technologies Corporation2011-02-18
KNOCKOUT SR MEDIUM, KNOCKOUT SR XENOFREE MEDIUM MODEL 10828, 12618 (K100616)Life Technologies Corporation2010-05-20
DULBECCO'S MODIFIED EAGLE MEDIUM (DMEM) (DEN000008)Life Technologies, Inc.2001-02-16

Recalls involving this device

RecordFirmDate
GIBCO CTS AIM V Serum-Free Media (SFM), Model Number 0870112BK. Tissue and cell culture me recall (Z-2543-2018)Life Technologies, Corp.2018-07-25

PMA approvals by this applicant

RecordFirmDate
SPOT-LIGHT HER2 CISH KIT (P050040/S003)Invitrogen Corporation2012-07-06
SPOT-LIGHT HER2 CISH KIT (P050040/S001)Invitrogen Corporation2011-07-12
SPOT-LIGHT HER2 CISH KIT (P050040/S002)Invitrogen Corporation2011-04-29
SPOT-LIGHT HER2 CISH KIT (P050040)Invitrogen Corporation2008-07-01